Veterinary Clinical Reference
Look up any drug or condition.
Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.
Metaldehyde Toxicosis in Dogs and Cats: Diagnosis and Treatment
A clinical reference for metaldehyde molluscicide exposure in dogs and cats, covering recognition, decontamination, tremor and seizure control, monitoring, ILE limitations, prognosis, and emerging extracorporeal evidence.
Read →Cholecalciferol rodenticide toxicosis in dogs and cats: dose calculation, monitoring, and treatment
A GP-facing clinical hub for vitamin D3 bait ingestion in dogs and cats: how to convert a 0.075% bait to a mg/kg dose at the desk, the 0.1 and 0.5 mg/kg decision thresholds, why hypercalcaemia is delayed and prolonged, decontamination and recheck intervals out to 72-96 hours, calcium-lowering agents with sourced doses, and how cholecalciferol differs from bromethalin and anticoagulant baits when the class is unknown.
Read →Bromethalin toxicosis in dogs and cats: dose calculation, decontamination and prognosis
No antidote, no antemortem test that returns in time, and a latency that makes an asymptomatic patient unreassuring. Convert bait grams to mg/kg of bromethalin, decontaminate from 0.1 mg/kg in dogs and 0.05 mg/kg in cats, and repeat the charcoal.
Read →Cisapride in cats and dogs: regulatory status, dosing, and cardiac safety
Cisapride has the broadest prokinetic reach of the drugs in common use, which is why it anchors medical management of feline constipation and early megacolon. It is also an unapproved, compounded-only drug with no controlled clinical trial in cats, a fifteenfold spread across published dose recommendations, and a hERG-mediated cardiac liability characterised in cats and dogs only at grossly supratherapeutic doses. This hub separates trial evidence from expert recommendation, quotes every dose figure from the source that printed it, and sets out where cisapride stops working — a failure of enteric nerves, not of muscle — and surgery begins.
Read →Battery ingestion in dogs and cats: emergency triage, removal and monitoring
Battery ingestion is two different emergencies and the radiograph decides which. A disc/button cell lodged in the oesophagus is an electrolytic burn that begins within minutes — canine experimental data show necrosis reaching the inner muscular layer at 15 minutes, and the trachea by one hour — and demands immediate endoscopic removal. A chewed cylindrical alkaline cell is a caustic-plus-foreign-body problem on a slower clock, where ulceration appears at 1-2 hours but the full extent of injury can take 24 hours. Covers first-two-minute triage, the injury mechanisms that separate the two cell types, what not to do (emesis, activated charcoal, oral acid), the radiographic double-rim and step-off signs, oesophageal versus gastric management, and how long to watch for delayed perforation and stricture.
Read →Sucralfate in Dogs and Cats: Dosing, Timing, and What the Evidence Supports
Sucralfate is a locally acting mucosal barrier agent that needs acid to work, not an acid suppressant. What the 2018 ACVIM consensus actually recommends, the PPI co-administration question, the quantified 2-hour drug-separation data in dogs, and dosing for both species.
Read →Metronidazole in Dogs and Cats: A Clinical Evidence Review
A clinical reference on metronidazole in dogs and cats: mechanism and spectrum, the randomised trials on acute diarrhoea, measured microbiome effects, the neurotoxicity dose-duration relationship, verbatim dosing, feline cautions, and stewardship-aligned alternatives.
Read →Famotidine in Dogs and Cats: A Clinical Reference
Famotidine works, modestly and briefly. A practising clinician's reference on where it sits versus omeprazole, the tachyphylaxis data in dogs and cats, the indications the evidence does not support, and when a PPI or nothing at all is the better call.
Read →Metoclopramide in Dogs and Cats: Antiemetic and Prokinetic Guide
A clinical reference on metoclopramide for dogs and cats: mechanism as a central D2 antiemetic and peripheral 5-HT4 prokinetic, verbatim intermittent and CRI dosing, indications for reflux and ileus, contraindications, adverse effects, and where it fits versus maropitant and ondansetron.
Read →Mushroom Toxicosis in Dogs and Cats: Amatoxin, Syndromic Triage, and Emergency Treatment
A clinician's guide to mushroom toxicosis in dogs and cats, leading with lethal amatoxin (Amanita) hepatotoxicosis and its deceptive biphasic course, then the full syndromic classification, time-of-onset triage, decontamination, and exact drug doses for each mushroom group.
Read →Paroxetine in Dogs and Cats
A DVM reference on extralabel paroxetine for canine and feline anxiety, aggression, and urine marking: verified dosing, onset, adverse effects, drug interactions, and how it compares with fluoxetine.
Read →Cane Toad (Bufo) Toxicosis in Dogs and Cats: Emergency Management
Emergency reference for bufonid toad toxicosis in dogs and cats. Bufadienolides inhibit Na+/K+-ATPase like digoxin while biogenic amines drive hypersalivation and hyperadrenergic signs; immediate oral lavage (never emesis), benzodiazepine seizure control, and rhythm-directed cardiac management anchor treatment, and Rhinella marina is the most toxic species.
Read →